{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:00:45Z","timestamp":1793847645257,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-05987-x","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:17:36Z","timestamp":1774592256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lower versus standard dose-intensity continuous renal replacement therapy: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"30","author":[{"given":"Nuttha","family":"Lumlertgul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prit","family":"Kusirisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice Y.","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u2019Arcy","family":"Duquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Wald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Bagshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"17","key":"5987_CR1","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa0902413","volume":"361","author":"RENAL Trial","year":"2009","unstructured":"Trial RENAL, Bellomo R, Cass A, Norton R, Gallagher M, Lo S, Su S, Cole L, Finfer S, McArthur C, et al. Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients. N Engl J Med. 2009;361(17):1627\u201338.","journal-title":"N Engl J Med"},{"issue":"1","key":"5987_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJMoa0802639","volume":"359","author":"PM VA\/NIH ATN Trial, Palevsky","year":"2008","unstructured":"VA\/NIH ATN Trial, Palevsky PM, Zhang JHY, O\u2019Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7\u201320.","journal-title":"N Engl J Med"},{"issue":"1","key":"5987_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):204.","journal-title":"Crit Care"},{"issue":"3","key":"5987_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1056\/NEJMoa2000741","volume":"383","author":"SM Bagshaw","year":"2020","unstructured":"Bagshaw SM, Wald R, Adhikari NKJ, Bellomo R, da Costa BR, Dreyfuss D, Gallagher MP, Gaudry S, Hoste EA, Lamontagne F, et al. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med. 2020;383(3):240\u201351.","journal-title":"N Engl J Med"},{"issue":"6","key":"5987_CR5","doi-asserted-by":"publisher","first-page":"100641","DOI":"10.1016\/j.xkme.2023.100641","volume":"5","author":"OG Rewa","year":"2023","unstructured":"Rewa OG, Ortiz-Soriano V, Lambert J, Kabir S, Heung M, House AA, Monga D, Juncos LA, Secic M, Piazza R, et al. Epidemiology and Outcomes of AKI Treated With Continuous Kidney Replacement Therapy: The Multicenter CRRTnet Study. Kidney Med. 2023;5(6):100641.","journal-title":"Kidney Med"},{"issue":"2","key":"5987_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ekir.2017.11.018","volume":"3","author":"A Vijayan","year":"2018","unstructured":"Vijayan A, Delos Santos RB, Li T, Goss CW, Palevsky PM. Effect of frequent dialysis on renal recovery: results from the Acute Renal Failure Trial Network Study. Kidney Int Rep. 2018;3(2):456\u201363.","journal-title":"Kidney Int Rep"},{"issue":"8","key":"5987_CR7","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2215\/CJN.10991015","volume":"11","author":"FR Mc Causland","year":"2016","unstructured":"Mc Causland FR, Asafu-Adjei J, Betensky RA, Palevsky PM, Waikar SS. Comparison of urine output among patients treated with more intensive versus less intensive RRT: results from the Acute Renal Failure Trial Network Study. Clin J Am Soc Nephrol. 2016;11(8):1335\u201342.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"5987_CR8","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.chest.2020.05.542","volume":"158","author":"S Sharma","year":"2020","unstructured":"Sharma S, Kelly YP, Palevsky PM, Waikar SS. Intensity of renal replacement therapy and duration of mechanical ventilation: secondary analysis of the Acute Renal Failure Trial Network Study. Chest. 2020;158(4):1473\u201381.","journal-title":"Chest"},{"issue":"6","key":"5987_CR9","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/ndt\/gfx308","volume":"33","author":"Y Wang","year":"2018","unstructured":"Wang Y, Gallagher M, Li Q, Lo S, Cass A, Finfer S, Myburgh J, Bouman C, Faulhaber-Walter R, Kellum JA, et al. Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: a systematic review and individual patient data meta-analysis. Nephrol Dial Transpl. 2018;33(6):1017\u201324.","journal-title":"Nephrol Dial Transpl"},{"issue":"1002","key":"5987_CR10","first-page":"14651858","volume":"4","author":"J Chandler","year":"2019","unstructured":"Chandler J, Cumpston M, Li T, Page MJ, Welch V. Cochrane handbook for systematic reviews of interventions. Hoboken: Wiley. 2019;4(1002):14651858.","journal-title":"Hoboken: Wiley"},{"issue":"1","key":"5987_CR11","doi-asserted-by":"publisher","first-page":"e112086","DOI":"10.1136\/bmjopen-2025-112086","volume":"16","author":"N Lumlertgul","year":"2026","unstructured":"Lumlertgul N, Kusirisin P, Kung JY, Duquette D, Fujii T, Zarbock A, Wald R, Bagshaw SM. Lower versus standard dose-intensity continuous renal replacement therapy: a protocol for a systematic review and meta-analysis. BMJ Open. 2026;16(1):e112086.","journal-title":"BMJ Open"},{"key":"5987_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"6","key":"5987_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5301\/ijao.5000610","volume":"40","author":"C Ronco","year":"2017","unstructured":"Ronco C. Continuous renal replacement therapy: forty-year anniversary. Int J Artif Organs. 2017;40(6):257\u201364.","journal-title":"Int J Artif Organs"},{"key":"5987_CR14","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"5987_CR15","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"5987_CR16","unstructured":"ROBINS-I tool (Risk Of Bias. In Non-randomized Studies - of Interventions) https:\/\/sites.google.com\/site\/riskofbiastool\/welcome\/home"},{"issue":"1","key":"5987_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000548371","volume":"55","author":"H Nakano","year":"2026","unstructured":"Nakano H, Inokuchi R, Inoue Y, Sekino M, Kakihana Y, Hattori N, Miyazaki M, Tokuhira N, Fujitani S, Toda Y, et al. Current Status of Continuous Renal Replacement Therapy in Japanese Intensive Care Units: A Multicenter Retrospective Observational Study. Blood Purif. 2026;55(1):1\u201312.","journal-title":"Blood Purif"},{"issue":"1","key":"5987_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","volume":"14","author":"J IntHout","year":"2014","unstructured":"IntHout J, Ioannidis JPA, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014;14(1):25.","journal-title":"BMC Med Res Methodol"},{"issue":"7109","key":"5987_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"4","key":"5987_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","volume":"16","author":"L Furuya-Kanamori","year":"2018","unstructured":"Furuya-Kanamori L, Barendregt JJ, Doi SAR. A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc. 2018;16(4):195\u2013203.","journal-title":"Int J Evid Based Healthc"},{"issue":"10","key":"5987_CR21","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1097\/00003246-200210000-00005","volume":"30","author":"CS Bouman","year":"2002","unstructured":"Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002;30(10):2205\u201311.","journal-title":"Crit Care Med"},{"issue":"6","key":"5987_CR22","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1681\/ASN.2007111173","volume":"19","author":"AJ Tolwani","year":"2008","unstructured":"Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol. 2008;19(6):1233\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"5987_CR23","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1186\/cc7784","volume":"13","author":"S Vesconi","year":"2009","unstructured":"Vesconi S, Cruz DN, Fumagalli R, Kindgen-Milles D, Monti G, Marinho A, Mariano F, Formica M, Marchesi M, Ren\u00e9 R, et al. Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care. 2009;13(2):R57.","journal-title":"Crit Care"},{"issue":"2","key":"5987_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jcrc.2010.09.004","volume":"26","author":"SA Nurmohamed","year":"2011","unstructured":"Nurmohamed SA, Koning MV, Vervloet MG, Groeneveld AB. Delivered dose of continuous venovenous hemofiltration predicts outcome in septic patients with acute kidney injury: a retrospective study. J Crit Care. 2011;26(2):213\u201320.","journal-title":"J Crit Care"},{"issue":"7","key":"5987_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5301\/ijao.5000110","volume":"35","author":"T Fujii","year":"2012","unstructured":"Fujii T, Namba Y, Fujitani S, Sasaki J, Narihara K, Shibagaki Y, Uchino S, Taira Y. Low-dose continuous renal replacement therapy for acute kidney injury. Int J Artif Organs. 2012;35(7):525\u201330.","journal-title":"Int J Artif Organs"},{"issue":"4","key":"5987_CR26","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.jtcvs.2014.05.006","volume":"148","author":"SY Li","year":"2014","unstructured":"Li SY, Yang WC, Chuang CL. Effect of early and intensive continuous venovenous hemofiltration on patients with cardiogenic shock and acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 2014;148(4):1628\u201333.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"11","key":"5987_CR27","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1097\/CCM.0b013e318298622e","volume":"41","author":"S Uchino","year":"2013","unstructured":"Uchino S, Toki N, Takeda K, Ohnuma T, Namba Y, Katayama S, Kawarazaki H, Yasuda H, Izawa J, Uji M, et al. Validity of low-intensity continuous renal replacement therapy*. Crit Care Med. 2013;41(11):2584\u201391.","journal-title":"Crit Care Med"},{"issue":"9","key":"5987_CR28","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1159\/000539810","volume":"53","author":"K Yagi","year":"2024","unstructured":"Yagi K, Fujii T, Kageyama A, Takagi T, Ikeda J, Uezono S. The effects of early-phase, low- or standard-intensity continuous renal replacement therapy on acid-base control and clinical outcomes: an observational study. Blood Purif. 2024;53(9):716\u201324.","journal-title":"Blood Purif"},{"issue":"2","key":"5987_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/SHK.0000000000002435","volume":"63","author":"MLM Faria","year":"2025","unstructured":"Faria MLM, Lib\u00f3rio AB, CONTINUOUS KIDNEY REPLACEMENT THERAPY DOSAGE AND MORTALITY IN CRITICALLY ILL PATIENTS. A RETROSPECTIVE COHORT STUDY USING MARGINAL STRUCTURAL MODEL. Shock. 2025;63(2):202\u20139.","journal-title":"Shock"},{"issue":"1","key":"5987_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40620-024-02142-z","volume":"38","author":"M Napoli","year":"2025","unstructured":"Napoli M, Gianfreda D, Matino S, Ria P, Zito A, Font\u00f2 G, Barbarini S, De Pascalis A. The role of a volume sparing strategy in kidney replacement therapy of AKI: a retrospective single-center study. J Nephrol. 2025;38(1):235\u201341.","journal-title":"J Nephrol"},{"issue":"2","key":"5987_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.ajkd.2024.01.526","volume":"84","author":"K Okamoto","year":"2024","unstructured":"Okamoto K, Fukushima H, Kawaguchi M, Tsuruya K. Low-Dose Continuous Kidney Replacement Therapy and Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Cohort Study. Am J Kidney Dis. 2024;84(2):145\u2013e153141.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"5987_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/SHK.0000000000000496","volume":"45","author":"K Mayumi","year":"2016","unstructured":"Mayumi K, Yamashita T, Hamasaki Y, Noiri E, Nangaku M, Yahagi N, et al. Impact of continuous renal replacement therapy intensity on septic acute kidney injury. Shock. 2016;45(2):133\u20138.","journal-title":"Shock"},{"issue":"5","key":"5987_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1186\/s13054-014-0539-4","volume":"18","author":"H Yasuda","year":"2014","unstructured":"Yasuda H, Uchino S, Uji M, Ohnuma T, Namba Y, Katayama S, Kawarazaki H, Toki N, Takeda K, Izawa J, et al. The lower limit of intensity to control uremia during continuous renal replacement therapy. Crit Care. 2014;18(5):539.","journal-title":"Crit Care"},{"issue":"9223","key":"5987_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0140-6736(00)02430-2","volume":"356","author":"C Ronco","year":"2000","unstructured":"Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356(9223):26\u201330.","journal-title":"Lancet"},{"issue":"2","key":"5987_CR35","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1186\/cc8933","volume":"14","author":"N Srisawat","year":"2010","unstructured":"Srisawat N, Lawsin L, Uchino S, Bellomo R, Kellum JA. Cost of acute renal replacement therapy in the intensive care unit: results from the beginning and ending supportive therapy for the kidney (BEST Kidney) study. Crit Care. 2010;14(2):R46.","journal-title":"Crit Care"},{"issue":"3","key":"5987_CR36","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/ndt\/gfr480","volume":"27","author":"WD Lyndon","year":"2012","unstructured":"Lyndon WD, Wille KM, Tolwani AJ. Solute clearance in CRRT: prescribed dose versus actual delivered dose. Nephrol Dial Transplant. 2012;27(3):952\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"5987_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04736-6","author":"L Zheng","year":"2026","unstructured":"Zheng L, Liang L, Wang X, Xu Y. Relationship between urine output and 28-day mortality in patients with acute kidney injury receiving continuous renal replacement therapy. BMC Nephrol. 2026;27(1):89. https:\/\/doi.org\/10.1186\/s12882-025-04736-6.","journal-title":"BMC Nephrol"},{"issue":"1","key":"5987_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13054-022-03988-0","volume":"26","author":"LS Chawla","year":"2022","unstructured":"Chawla LS. Permissive azotemia during acute kidney injury enables more rapid renal recovery and less renal fibrosis: a hypothesis and clinical development plan. Crit Care. 2022;26(1):116.","journal-title":"Crit Care"},{"issue":"6","key":"5987_CR39","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/ndt\/gft040","volume":"28","author":"RA Zager","year":"2013","unstructured":"Zager RA, Johnson AC, Becker K. Post-ischemic azotemia as a partial \u2018brake\u2019, slowing progressive kidney disease. Nephrol Dial Transplant. 2013;28(6):1455\u201362.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"5987_CR40","doi-asserted-by":"publisher","first-page":"F362","DOI":"10.1152\/ajprenal.90645.2008","volume":"296","author":"RA Zager","year":"2009","unstructured":"Zager RA. Uremia induces proximal tubular cytoresistance and heme oxygenase-1 expression in the absence of acute kidney injury. Am J Physiol Renal Physiol. 2009;296(2):F362-368.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"5987_CR41","doi-asserted-by":"publisher","first-page":"e105459","DOI":"10.1136\/bmjopen-2025-105459","volume":"15","author":"C Strau\u00df","year":"2025","unstructured":"Strau\u00df C, Sadjadi M, von Groote T, Booke H, Sch\u00f6ne LM, Hegner C, Wempe C, Meersch M, Gerss J, Bernard A, et al. Randomised controlled study investigating standard dose continuous renal replacement therapy (CRRT) versus low-dose CRRT in critically ill patients with acute kidney injury (AKI): study protocol for a prospective, randomised, controlled, international, multicentre trial (the \u2018Ketzerei\u2019 trial). BMJ Open. 2025;15(9):e105459.","journal-title":"BMJ Open"},{"issue":"1","key":"5987_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJMoa0802639","volume":"359","author":"PM Palevsky","year":"2008","unstructured":"Palevsky PM, Zhang JH, O\u2019Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7\u201320.","journal-title":"N Engl J Med"},{"issue":"17","key":"5987_CR43","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa0902413","volume":"361","author":"R Bellomo","year":"2009","unstructured":"Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361(17):1627\u201338.","journal-title":"N Engl J Med"},{"issue":"1","key":"5987_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11255-011-0112-x","volume":"45","author":"H Schiffl","year":"2013","unstructured":"Schiffl H, Lang SM. Severe acute hypophosphatemia during renal replacement therapy adversely affects outcome of critically ill patients with acute kidney injury. Int Urol Nephrol. 2013;45(1):191\u20137.","journal-title":"Int Urol Nephrol"},{"issue":"12","key":"5987_CR45","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1093\/ndt\/gfac159","volume":"37","author":"F Di Mario","year":"2022","unstructured":"Di Mario F, Regolisti G, Maggiore U, Pacchiarini MC, Menegazzo B, Greco P, Maccari C, Zambrano C, Cantarelli C, Pistolesi V, et al. Hypophosphatemia in critically ill patients undergoing Sustained Low-Efficiency Dialysis with standard dialysis solutions. Nephrol Dial Transpl. 2022;37(12):2505\u201313.","journal-title":"Nephrol Dial Transpl"},{"issue":"11","key":"5987_CR46","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1093\/ndt\/gfr075","volume":"26","author":"S Demirjian","year":"2011","unstructured":"Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, et al. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant. 2011;26(11):3508\u201314.","journal-title":"Nephrol Dial Transplant"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-05987-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:11:15Z","timestamp":1789459875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-05987-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5987"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-05987-x","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SMB has received fees for scientific advisory from BioPorto, CalciMedica, Novartis, and Vantive; and has received grant support from Vantive. TF has received grants from the Japanese Society for the Promotion of Science, Terumo Life Science Foundation, Japan Research Foundation for Clinical Pharmacology for the ongoing clinical trial mentioned in this study. RW has received consulting and speaker fees from Vantive.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"232"}}